# Centauri Therapeutics

**Source:** https://www.startuphub.ai/startups/centauri-therapeutics
**Profile type:** Startup

> Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR).

## About

Centauri Therapeutics is a biotechnology company based in Alderley Park, UK, focused on the discovery and development of novel therapeutics for serious diseases. Leveraging its proprietary Alphamer® platform, the company develops immunotherapies that harness the body's natural immune response to fight life-threatening infections, particularly multi-drug resistant Gram-negative bacteria. The platform also has initial proof-of-concept data in oncology, expanding therapeutic options for vulnerable patients.

## Key facts

- **Slug:** centauri-therapeutics
- **Website:** https://www.centauritherapeutics.com/
- **Location:** Oxford, England, United Kingdom
- **Founded:** 2013-00-00 00:00:00
- **Operating status:** Active
- **Total funding:** $57M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/centauri-therapeutics/

## Frequently asked

### What does Centauri Therapeutics do?

Centauri Therapeutics is a biotechnology company based in Alderley Park, UK, focused on the discovery and development of novel therapeutics for serious diseases. Leveraging its proprietary Alphamer® platform, the company develops immunotherapies that harness the body's natural immune response to fight life-threatening infections, particularly multi-drug resistant Gram-negative bacteria. The platform also has initial proof-of-concept data in oncology, expanding therapeutic options for vulnerable…

### What is Centauri Therapeutics's revenue?

StartupHub estimates Centauri Therapeutics's annual revenue at $2.8M (range $1.5M to $7.9M, 44% confidence), based on comparable companies in the sector.

### What is Centauri Therapeutics's valuation?

StartupHub estimates Centauri Therapeutics's effective valuation at $13.6M (range $4.8M to $26.2M, 56% confidence), based on comparable companies in the sector.

### How much funding has Centauri Therapeutics raised?

Centauri Therapeutics has raised a total of $57M in funding. The most recent round on record is Series A.

### Where is Centauri Therapeutics headquartered?

Centauri Therapeutics is headquartered in Oxford, England, United Kingdom.

### What industry does Centauri Therapeutics operate in?

Centauri Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Centauri Therapeutics",
          "item": "https://www.startuphub.ai/startups/centauri-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/centauri-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/centauri-therapeutics",
      "name": "Centauri Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Centauri Therapeutics. Centauri Therapeutics is a startup founded in 2013, operating in Biotechnology and Pharmaceuticals. Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR). Headquartered in Oxford, England, United Kingdom.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/centauri-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/centauri-therapeutics#organization",
      "name": "Centauri Therapeutics",
      "url": "https://www.centauritherapeutics.com/",
      "description": "This is the official profile of Centauri Therapeutics. Centauri Therapeutics is a startup founded in 2013, operating in Biotechnology and Pharmaceuticals. Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR). Headquartered in Oxford, England, United Kingdom.",
      "sameAs": [
        "https://www.linkedin.com/company/centauri-therapeutics/",
        "https://www.startuphub.ai/startups/centauri-therapeutics"
      ],
      "foundingDate": "2013-00-00 00:00:00",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Oxford",
        "addressRegion": "England",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Drug Discovery",
        "Antimicrobial Resistance"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/centauri-therapeutics#profile-assessment",
      "name": "Centauri Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/centauri-therapeutics",
      "category": "Biotechnology",
      "description": "This is the official profile of Centauri Therapeutics. Centauri Therapeutics is a startup founded in 2013, operating in Biotechnology and Pharmaceuticals. Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR). Headquartered in Oxford, England, United Kingdom. Agent Readiness score: 42/100. Full audit: https://www.startuphub.ai/startups/centauri-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Centauri Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "Centauri Therapeutics - Profile Score 49/100",
        "reviewBody": "This is the official profile of Centauri Therapeutics. Centauri Therapeutics is a startup founded in 2013, operating in Biotechnology and Pharmaceuticals. Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR). Headquartered in Oxford, England, United Kingdom. Agent Readiness score: 42/100. Full audit: https://www.startuphub.ai/startups/centauri-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 49,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```